Table of Content

1 Report Overview
1.1 RNA Drugs Definition
1.2 Market by Type
1.2.1 Global RNA Drugs Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 siRNA
1.2.3 ASO
1.2.4 miRNA
1.2.5 Nucleic Acid Aptamers
1.3 Market Segment by Application
1.3.1 Global RNA Drugs Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Tuberculosis
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global RNA Drugs Sales
2.1 Global RNA Drugs Revenue Estimates and Forecasts 2018-2034
2.2 Global RNA Drugs Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global RNA Drugs Revenue by Region
2.3.1 Global RNA Drugs Revenue by Region (2018-2023)
2.3.2 Global RNA Drugs Revenue by Region (2024-2034)
2.4 Global RNA Drugs Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global RNA Drugs Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global RNA Drugs Sales Quantity by Region
2.6.1 Global RNA Drugs Sales Quantity by Region (2018-2023)
2.6.2 Global RNA Drugs Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global RNA Drugs Sales Quantity by Manufacturers
3.1.1 Global RNA Drugs Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global RNA Drugs Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by RNA Drugs Sales in 2024
3.2 Global RNA Drugs Revenue by Manufacturers
3.2.1 Global RNA Drugs Revenue by Manufacturers (2018-2023)
3.2.2 Global RNA Drugs Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by RNA Drugs Revenue in 2024
3.3 Global RNA Drugs Sales Price by Manufacturers
3.4 Global Key Players of RNA Drugs, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global RNA Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of RNA Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of RNA Drugs, Product Offered and Application
3.8 Global Key Manufacturers of RNA Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global RNA Drugs Sales Quantity by Type
4.1.1 Global RNA Drugs Historical Sales Quantity by Type (2018-2023)
4.1.2 Global RNA Drugs Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global RNA Drugs Sales Quantity Market Share by Type (2018-2034)
4.2 Global RNA Drugs Revenue by Type
4.2.1 Global RNA Drugs Historical Revenue by Type (2018-2023)
4.2.2 Global RNA Drugs Forecasted Revenue by Type (2024-2034)
4.2.3 Global RNA Drugs Revenue Market Share by Type (2018-2034)
4.3 Global RNA Drugs Price by Type
4.3.1 Global RNA Drugs Price by Type (2018-2023)
4.3.2 Global RNA Drugs Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global RNA Drugs Sales Quantity by Application
5.1.1 Global RNA Drugs Historical Sales Quantity by Application (2018-2023)
5.1.2 Global RNA Drugs Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global RNA Drugs Sales Quantity Market Share by Application (2018-2034)
5.2 Global RNA Drugs Revenue by Application
5.2.1 Global RNA Drugs Historical Revenue by Application (2018-2023)
5.2.2 Global RNA Drugs Forecasted Revenue by Application (2024-2034)
5.2.3 Global RNA Drugs Revenue Market Share by Application (2018-2034)
5.3 Global RNA Drugs Price by Application
5.3.1 Global RNA Drugs Price by Application (2018-2023)
5.3.2 Global RNA Drugs Price Forecast by Application (2024-2034)
6 North America
6.1 North America RNA Drugs Sales by Company
6.1.1 North America RNA Drugs Revenue by Company (2018-2023)
6.1.2 North America RNA Drugs Sales Quantity by Company (2018-2023)
6.2 North America RNA Drugs Market Size by Type
6.2.1 North America RNA Drugs Sales Quantity by Type (2018-2034)
6.2.2 North America RNA Drugs Revenue by Type (2018-2034)
6.3 North America RNA Drugs Market Size by Application
6.3.1 North America RNA Drugs Sales Quantity by Application (2018-2034)
6.3.2 North America RNA Drugs Revenue by Application (2018-2034)
6.4 North America RNA Drugs Market Size by Country
6.4.1 North America RNA Drugs Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America RNA Drugs Revenue by Country (2018-2034)
6.4.3 North America RNA Drugs Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe RNA Drugs Sales by Company
7.1.1 Europe RNA Drugs Sales Quantity by Company (2018-2023)
7.1.2 Europe RNA Drugs Revenue by Company (2018-2023)
7.2 Europe RNA Drugs Market Size by Type
7.2.1 Europe RNA Drugs Sales Quantity by Type (2018-2034)
7.2.2 Europe RNA Drugs Revenue by Type (2018-2034)
7.3 Europe RNA Drugs Market Size by Application
7.3.1 Europe RNA Drugs Sales Quantity by Application (2018-2034)
7.3.2 Europe RNA Drugs Revenue by Application (2018-2034)
7.4 Europe RNA Drugs Market Size by Country
7.4.1 Europe RNA Drugs Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe RNA Drugs Revenue by Country (2018-2034)
7.4.3 Europe RNA Drugs Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China RNA Drugs Sales by Company
8.1.1 China RNA Drugs Sales Quantity by Company (2018-2023)
8.1.2 China RNA Drugs Revenue by Company (2018-2023)
8.2 China RNA Drugs Market Size by Type
8.2.1 China RNA Drugs Sales Quantity by Type (2018-2034)
8.2.2 China RNA Drugs Revenue by Type (2018-2034)
8.3 China RNA Drugs Market Size by Application
8.3.1 China RNA Drugs Sales Quantity by Application (2018-2034)
8.3.2 China RNA Drugs Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC RNA Drugs Sales by Company
9.1.1 APAC RNA Drugs Sales Quantity by Company (2018-2023)
9.1.2 APAC RNA Drugs Revenue by Company (2018-2023)
9.2 APAC RNA Drugs Market Size by Type
9.2.1 APAC RNA Drugs Sales Quantity by Type (2018-2034)
9.2.2 APAC RNA Drugs Revenue by Type (2018-2034)
9.3 APAC RNA Drugs Market Size by Application
9.3.1 APAC RNA Drugs Sales Quantity by Application (2018-2034)
9.3.2 APAC RNA Drugs Revenue by Application (2018-2034)
9.4 APAC RNA Drugs Market Size by Region
9.4.1 APAC RNA Drugs Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC RNA Drugs Revenue by Region (2018-2034)
9.4.3 APAC RNA Drugs Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America RNA Drugs Sales by Company
10.1.1 Middle East, Africa and Latin America RNA Drugs Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America RNA Drugs Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America RNA Drugs Market Size by Type
10.2.1 Middle East, Africa and Latin America RNA Drugs Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America RNA Drugs Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America RNA Drugs Market Size by Application
10.3.1 Middle East, Africa and Latin America RNA Drugs Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America RNA Drugs Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America RNA Drugs Market Size by Country
10.4.1 Middle East, Africa and Latin America RNA Drugs Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America RNA Drugs Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America RNA Drugs Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer RNA Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Pfizer RNA Drugs Products and Services
11.1.5 Pfizer RNA Drugs SWOT Analysis
11.1.6 Pfizer Recent Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Overview
11.2.3 Roche RNA Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Roche RNA Drugs Products and Services
11.2.5 Roche RNA Drugs SWOT Analysis
11.2.6 Roche Recent Developments
11.3 Sanofi-Aventis
11.3.1 Sanofi-Aventis Company Information
11.3.2 Sanofi-Aventis Overview
11.3.3 Sanofi-Aventis RNA Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Sanofi-Aventis RNA Drugs Products and Services
11.3.5 Sanofi-Aventis RNA Drugs SWOT Analysis
11.3.6 Sanofi-Aventis Recent Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Information
11.4.2 Abbott Laboratories Overview
11.4.3 Abbott Laboratories RNA Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Abbott Laboratories RNA Drugs Products and Services
11.4.5 Abbott Laboratories RNA Drugs SWOT Analysis
11.4.6 Abbott Laboratories Recent Developments
11.5 Arrowhead Pharmaceuticals
11.5.1 Arrowhead Pharmaceuticals Company Information
11.5.2 Arrowhead Pharmaceuticals Overview
11.5.3 Arrowhead Pharmaceuticals RNA Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Arrowhead Pharmaceuticals RNA Drugs Products and Services
11.5.5 Arrowhead Pharmaceuticals RNA Drugs SWOT Analysis
11.5.6 Arrowhead Pharmaceuticals Recent Developments
11.6 Benitec Biopharma
11.6.1 Benitec Biopharma Company Information
11.6.2 Benitec Biopharma Overview
11.6.3 Benitec Biopharma RNA Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Benitec Biopharma RNA Drugs Products and Services
11.6.5 Benitec Biopharma RNA Drugs SWOT Analysis
11.6.6 Benitec Biopharma Recent Developments
11.7 Calimmune Inc
11.7.1 Calimmune Inc Company Information
11.7.2 Calimmune Inc Overview
11.7.3 Calimmune Inc RNA Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Calimmune Inc RNA Drugs Products and Services
11.7.5 Calimmune Inc RNA Drugs SWOT Analysis
11.7.6 Calimmune Inc Recent Developments
11.8 Dicerna
11.8.1 Dicerna Company Information
11.8.2 Dicerna Overview
11.8.3 Dicerna RNA Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Dicerna RNA Drugs Products and Services
11.8.5 Dicerna RNA Drugs SWOT Analysis
11.8.6 Dicerna Recent Developments
11.9 Gradalis
11.9.1 Gradalis Company Information
11.9.2 Gradalis Overview
11.9.3 Gradalis RNA Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Gradalis RNA Drugs Products and Services
11.9.5 Gradalis RNA Drugs SWOT Analysis
11.9.6 Gradalis Recent Developments
11.10 Quark
11.10.1 Quark Company Information
11.10.2 Quark Overview
11.10.3 Quark RNA Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Quark RNA Drugs Products and Services
11.10.5 Quark RNA Drugs SWOT Analysis
11.10.6 Quark Recent Developments
11.11 RXi
11.11.1 RXi Company Information
11.11.2 RXi Overview
11.11.3 RXi RNA Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 RXi RNA Drugs Products and Services
11.11.5 RXi Recent Developments
11.12 Senesco
11.12.1 Senesco Company Information
11.12.2 Senesco Overview
11.12.3 Senesco RNA Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.12.4 Senesco RNA Drugs Products and Services
11.12.5 Senesco Recent Developments
11.13 Silence Therapeutics
11.13.1 Silence Therapeutics Company Information
11.13.2 Silence Therapeutics Overview
11.13.3 Silence Therapeutics RNA Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.13.4 Silence Therapeutics RNA Drugs Products and Services
11.13.5 Silence Therapeutics Recent Developments
11.14 Silenseed
11.14.1 Silenseed Company Information
11.14.2 Silenseed Overview
11.14.3 Silenseed RNA Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.14.4 Silenseed RNA Drugs Products and Services
11.14.5 Silenseed Recent Developments
11.15 Tekmira
11.15.1 Tekmira Company Information
11.15.2 Tekmira Overview
11.15.3 Tekmira RNA Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.15.4 Tekmira RNA Drugs Products and Services
11.15.5 Tekmira Recent Developments
11.16 Alnylam Pharmaceuticals
11.16.1 Alnylam Pharmaceuticals Company Information
11.16.2 Alnylam Pharmaceuticals Overview
11.16.3 Alnylam Pharmaceuticals RNA Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.16.4 Alnylam Pharmaceuticals RNA Drugs Products and Services
11.16.5 Alnylam Pharmaceuticals Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 RNA Drugs Value Chain Analysis
12.2 RNA Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 RNA Drugs Production Mode & Process
12.4 RNA Drugs Sales and Marketing
12.4.1 RNA Drugs Sales Channels
12.4.2 RNA Drugs Distributors
12.5 RNA Drugs Customers
13 Market Dynamics
13.1 RNA Drugs Industry Trends
13.2 RNA Drugs Market Drivers
13.3 RNA Drugs Market Challenges
13.4 RNA Drugs Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global RNA Drugs Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of siRNA
Table 3. Major Manufacturers of ASO
Table 4. Major Manufacturers of miRNA
Table 5. Major Manufacturers of Nucleic Acid Aptamers
Table 6. Global RNA Drugs Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global RNA Drugs Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global RNA Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global RNA Drugs Revenue Market Share by Region (2018-2023)
Table 10. Global RNA Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global RNA Drugs Revenue Market Share by Region (2024-2034)
Table 12. Global RNA Drugs Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 13. Global RNA Drugs Sales by Region (2018-2023) & (K Units)
Table 14. Global RNA Drugs Sales Market Share by Region (2018-2023)
Table 15. Global RNA Drugs Sales by Region (2024-2034) & (K Units)
Table 16. Global RNA Drugs Sales Market Share by Region (2024-2034)
Table 17. Global RNA Drugs Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 18. Global RNA Drugs Sales Quantity Share by Manufacturers (2018-2023)
Table 19. Global RNA Drugs Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global RNA Drugs Revenue Share by Manufacturers (2018-2023)
Table 21. Global RNA Drugs Price by Manufacturers 2018-2023 (USD/Unit)
Table 22. Global Key Players of RNA Drugs, Industry Ranking, 2021 VS 2024
Table 23. Global RNA Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global RNA Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA Drugs as of 2024)
Table 25. Global Key Manufacturers of RNA Drugs, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of RNA Drugs, Product Offered and Application
Table 27. Global Key Manufacturers of RNA Drugs, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global RNA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 30. Global RNA Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 31. Global RNA Drugs Sales Quantity Share by Type (2018-2023)
Table 32. Global RNA Drugs Sales Quantity Share by Type (2024-2034)
Table 33. Global RNA Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global RNA Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global RNA Drugs Revenue Share by Type (2018-2023)
Table 36. Global RNA Drugs Revenue Share by Type (2024-2034)
Table 37. RNA Drugs Price by Type (2018-2023) & (USD/Unit)
Table 38. Global RNA Drugs Price Forecast by Type (2024-2034) & (USD/Unit)
Table 39. Global RNA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 40. Global RNA Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 41. Global RNA Drugs Sales Quantity Share by Application (2018-2023)
Table 42. Global RNA Drugs Sales Quantity Share by Application (2024-2034)
Table 43. Global RNA Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global RNA Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global RNA Drugs Revenue Share by Application (2018-2023)
Table 46. Global RNA Drugs Revenue Share by Application (2024-2034)
Table 47. RNA Drugs Price by Application (2018-2023) & (USD/Unit)
Table 48. Global RNA Drugs Price Forecast by Application (2024-2034) & (USD/Unit)
Table 49. North America RNA Drugs Revenue by Company (2018-2023) & (US$ Million)
Table 50. North America RNA Drugs Sales Quantity by Company (2018-2023) & (K Units)
Table 51. North America RNA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 52. North America RNA Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 53. North America RNA Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 54. North America RNA Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America RNA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 56. North America RNA Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 57. North America RNA Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 58. North America RNA Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America RNA Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 60. North America RNA Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 61. North America RNA Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America RNA Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 63. North America RNA Drugs Sales Quantity by Country (2024-2034) & (K Units)
Table 64. Europe RNA Drugs Sales Quantity by Company (2018-2023) & (K Units)
Table 65. Europe RNA Drugs Revenue by Company (2018-2023) & (US$ Million)
Table 66. Europe RNA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 67. Europe RNA Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 68. Europe RNA Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 69. Europe RNA Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe RNA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 71. Europe RNA Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 72. Europe RNA Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 73. Europe RNA Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe RNA Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 75. Europe RNA Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 76. Europe RNA Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe RNA Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 78. Europe RNA Drugs Sales Quantity by Country (2024-2034) & (K Units)
Table 79. China RNA Drugs Sales Quantity by Company (2018-2023) & (K Units)
Table 80. China RNA Drugs Revenue by Company (2018-2023) & (US$ Million)
Table 81. China RNA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 82. China RNA Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 83. China RNA Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 84. China RNA Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 85. China RNA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 86. China RNA Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 87. China RNA Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 88. China RNA Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC RNA Drugs Sales Quantity by Company (2018-2023) & (K Units)
Table 90. APAC RNA Drugs Revenue by Company (2018-2023) & (US$ Million)
Table 91. APAC RNA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 92. APAC RNA Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 93. APAC RNA Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 94. APAC RNA Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC RNA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 96. APAC RNA Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 97. APAC RNA Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 98. APAC RNA Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC RNA Drugs Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 100. APAC RNA Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 101. APAC RNA Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC RNA Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 103. APAC RNA Drugs Sales Quantity by Region (2024-2034) & (K Units)
Table 104. Middle East, Africa and Latin America RNA Drugs Sales Quantity by Company (2018-2023) & (K Units)
Table 105. Middle East, Africa and Latin America RNA Drugs Revenue by Company (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America RNA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Middle East, Africa and Latin America RNA Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 108. Middle East, Africa and Latin America RNA Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America RNA Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America RNA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Middle East, Africa and Latin America RNA Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 112. Middle East, Africa and Latin America RNA Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 113. Middle East, Africa and Latin America RNA Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America RNA Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America RNA Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 116. Middle East, Africa and Latin America RNA Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America RNA Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Middle East, Africa and Latin America RNA Drugs Sales Quantity by Country (2024-2034) & (K Units)
Table 119. Pfizer Company Information
Table 120. Pfizer Description and Overview
Table 121. Pfizer RNA Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 122. Pfizer RNA Drugs Product and Services
Table 123. Pfizer RNA Drugs SWOT Analysis
Table 124. Pfizer Recent Developments
Table 125. Roche Company Information
Table 126. Roche Description and Overview
Table 127. Roche RNA Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 128. Roche RNA Drugs Product and Services
Table 129. Roche RNA Drugs SWOT Analysis
Table 130. Roche Recent Developments
Table 131. Sanofi-Aventis Company Information
Table 132. Sanofi-Aventis Description and Overview
Table 133. Sanofi-Aventis RNA Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 134. Sanofi-Aventis RNA Drugs Product and Services
Table 135. Sanofi-Aventis RNA Drugs SWOT Analysis
Table 136. Sanofi-Aventis Recent Developments
Table 137. Abbott Laboratories Company Information
Table 138. Abbott Laboratories Description and Overview
Table 139. Abbott Laboratories RNA Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 140. Abbott Laboratories RNA Drugs Product and Services
Table 141. Abbott Laboratories RNA Drugs SWOT Analysis
Table 142. Abbott Laboratories Recent Developments
Table 143. Arrowhead Pharmaceuticals Company Information
Table 144. Arrowhead Pharmaceuticals Description and Overview
Table 145. Arrowhead Pharmaceuticals RNA Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 146. Arrowhead Pharmaceuticals RNA Drugs Product and Services
Table 147. Arrowhead Pharmaceuticals RNA Drugs SWOT Analysis
Table 148. Arrowhead Pharmaceuticals Recent Developments
Table 149. Benitec Biopharma Company Information
Table 150. Benitec Biopharma Description and Overview
Table 151. Benitec Biopharma RNA Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 152. Benitec Biopharma RNA Drugs Product and Services
Table 153. Benitec Biopharma RNA Drugs SWOT Analysis
Table 154. Benitec Biopharma Recent Developments
Table 155. Calimmune Inc Company Information
Table 156. Calimmune Inc Description and Overview
Table 157. Calimmune Inc RNA Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 158. Calimmune Inc RNA Drugs Product and Services
Table 159. Calimmune Inc RNA Drugs SWOT Analysis
Table 160. Calimmune Inc Recent Developments
Table 161. Dicerna Company Information
Table 162. Dicerna Description and Overview
Table 163. Dicerna RNA Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 164. Dicerna RNA Drugs Product and Services
Table 165. Dicerna RNA Drugs SWOT Analysis
Table 166. Dicerna Recent Developments
Table 167. Gradalis Company Information
Table 168. Gradalis Description and Overview
Table 169. Gradalis RNA Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 170. Gradalis RNA Drugs Product and Services
Table 171. Gradalis RNA Drugs SWOT Analysis
Table 172. Gradalis Recent Developments
Table 173. Quark Company Information
Table 174. Quark Description and Overview
Table 175. Quark RNA Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 176. Quark RNA Drugs Product and Services
Table 177. Quark RNA Drugs SWOT Analysis
Table 178. Quark Recent Developments
Table 179. RXi Company Information
Table 180. RXi Description and Overview
Table 181. RXi RNA Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 182. RXi RNA Drugs Product and Services
Table 183. RXi Recent Developments
Table 184. Senesco Company Information
Table 185. Senesco Description and Overview
Table 186. Senesco RNA Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 187. Senesco RNA Drugs Product and Services
Table 188. Senesco Recent Developments
Table 189. Silence Therapeutics Company Information
Table 190. Silence Therapeutics Description and Overview
Table 191. Silence Therapeutics RNA Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 192. Silence Therapeutics RNA Drugs Product and Services
Table 193. Silence Therapeutics Recent Developments
Table 194. Silenseed Company Information
Table 195. Silenseed Description and Overview
Table 196. Silenseed RNA Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 197. Silenseed RNA Drugs Product and Services
Table 198. Silenseed Recent Developments
Table 199. Tekmira Company Information
Table 200. Tekmira Description and Overview
Table 201. Tekmira RNA Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 202. Tekmira RNA Drugs Product and Services
Table 203. Tekmira Recent Developments
Table 204. Alnylam Pharmaceuticals Company Information
Table 205. Alnylam Pharmaceuticals Description and Overview
Table 206. Alnylam Pharmaceuticals RNA Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 207. Alnylam Pharmaceuticals RNA Drugs Product and Services
Table 208. Alnylam Pharmaceuticals Recent Developments
Table 209. Key Raw Materials Lists
Table 210. Raw Materials Key Suppliers Lists
Table 211. RNA Drugs Distributors List
Table 212. RNA Drugs Customers List
Table 213. RNA Drugs Market Trends
Table 214. RNA Drugs Market Drivers
Table 215. RNA Drugs Market Challenges
Table 216. RNA Drugs Market Restraints
Table 217. Research Programs/Design for This Report
Table 218. Key Data Information from Secondary Sources
Table 219. Key Data Information from Primary Sources
List of Figures
Figure 1. RNA Drugs Product Picture
Figure 2. Global RNA Drugs Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global RNA Drugs Market Share by Type in 2024 & 2034
Figure 4. siRNA Product Picture
Figure 5. ASO Product Picture
Figure 6. miRNA Product Picture
Figure 7. Nucleic Acid Aptamers Product Picture
Figure 8. Global RNA Drugs Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 9. Global RNA Drugs Market Share by Application in 2024 & 2034
Figure 10. Cancer
Figure 11. Diabetes
Figure 12. Tuberculosis
Figure 13. Cardiovascular Diseases
Figure 14. Others
Figure 15. RNA Drugs Report Years Considered
Figure 16. Global RNA Drugs Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 17. Global RNA Drugs Revenue 2018-2034 (US$ Million)
Figure 18. Global RNA Drugs Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 19. Global RNA Drugs Sales Quantity 2018-2034 (K Units)
Figure 20. Global RNA Drugs Sales Quantity Market Share by Region (2018-2023)
Figure 21. Global RNA Drugs Sales Quantity Market Share by Region (2024-2034)
Figure 22. North America RNA Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. North America RNA Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 24. Europe RNA Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. Europe RNA Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 26. China RNA Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. China RNA Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 28. APAC RNA Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 29. APAC RNA Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 30. Middle East, Africa and Latin America RNA Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 31. Middle East, Africa and Latin America RNA Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 32. The Top 10 and Top 5 Players Market Share by RNA Drugs Sales Quantity in 2024
Figure 33. The Top 10 and Top 5 Players Market Share by RNA Drugs Revenue in 2024
Figure 34. RNA Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 35. Global RNA Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 36. Global RNA Drugs Revenue Market Share by Type (2018-2034)
Figure 37. Global RNA Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 38. Global RNA Drugs Revenue Market Share by Application (2018-2034)
Figure 39. North America RNA Drugs Revenue Market Share by Company in 2024
Figure 40. North America RNA Drugs Sales Quantity Market Share by Company in 2024
Figure 41. North America RNA Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 42. North America RNA Drugs Revenue Market Share by Type (2018-2034)
Figure 43. North America RNA Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 44. North America RNA Drugs Revenue Market Share by Application (2018-2034)
Figure 45. North America RNA Drugs Revenue Share by Country (2018-2034)
Figure 46. North America RNA Drugs Sales Quantity Share by Country (2018-2034)
Figure 47. U.S. RNA Drugs Revenue (2018-2034) & (US$ Million)
Figure 48. Canada RNA Drugs Revenue (2018-2034) & (US$ Million)
Figure 49. Europe RNA Drugs Sales Quantity Market Share by Company in 2024
Figure 50. Europe RNA Drugs Revenue Market Share by Company in 2024
Figure 51. Europe RNA Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 52. Europe RNA Drugs Revenue Market Share by Type (2018-2034)
Figure 53. Europe RNA Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 54. Europe RNA Drugs Revenue Market Share by Application (2018-2034)
Figure 55. Europe RNA Drugs Revenue Share by Country (2018-2034)
Figure 56. Europe RNA Drugs Sales Quantity Share by Country (2018-2034)
Figure 57. Germany RNA Drugs Revenue (2018-2034) & (US$ Million)
Figure 58. France RNA Drugs Revenue (2018-2034) & (US$ Million)
Figure 59. U.K. RNA Drugs Revenue (2018-2034) & (US$ Million)
Figure 60. Italy RNA Drugs Revenue (2018-2034) & (US$ Million)
Figure 61. Russia RNA Drugs Revenue (2018-2034) & (US$ Million)
Figure 62. China RNA Drugs Sales Quantity Market Share by Company in 2024
Figure 63. China RNA Drugs Revenue Market Share by Company in 2024
Figure 64. China RNA Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 65. China RNA Drugs Revenue Market Share by Type (2018-2034)
Figure 66. China RNA Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 67. China RNA Drugs Revenue Market Share by Application (2018-2034)
Figure 68. APAC RNA Drugs Sales Quantity Market Share by Company in 2024
Figure 69. APAC RNA Drugs Revenue Market Share by Company in 2024
Figure 70. APAC RNA Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 71. APAC RNA Drugs Revenue Market Share by Type (2018-2034)
Figure 72. APAC RNA Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 73. APAC RNA Drugs Revenue Market Share by Application (2018-2034)
Figure 74. APAC RNA Drugs Revenue Share by Region (2018-2034)
Figure 75. APAC RNA Drugs Sales Quantity Share by Region (2018-2034)
Figure 76. Japan RNA Drugs Revenue (2018-2034) & (US$ Million)
Figure 77. South Korea RNA Drugs Revenue (2018-2034) & (US$ Million)
Figure 78. China Taiwan RNA Drugs Revenue (2018-2034) & (US$ Million)
Figure 79. Southeast Asia RNA Drugs Revenue (2018-2034) & (US$ Million)
Figure 80. India RNA Drugs Revenue (2018-2034) & (US$ Million)
Figure 81. Middle East, Africa and Latin America RNA Drugs Sales Quantity Market Share by Company in 2024
Figure 82. Middle East, Africa and Latin America RNA Drugs Revenue Market Share by Company in 2024
Figure 83. Middle East, Africa and Latin America RNA Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America RNA Drugs Revenue Market Share by Type (2018-2034)
Figure 85. Middle East, Africa and Latin America RNA Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America RNA Drugs Revenue Market Share by Application (2018-2034)
Figure 87. Middle East, Africa and Latin America RNA Drugs Sales Quantity Share by Country (2018-2034)
Figure 88. Middle East, Africa and Latin America RNA Drugs Revenue Share by Country (2018-2034)
Figure 89. Brazil RNA Drugs Revenue (2018-2034) & (US$ Million)
Figure 90. Mexico RNA Drugs Revenue (2018-2034) & (US$ Million)
Figure 91. Turkey RNA Drugs Revenue (2018-2034) & (US$ Million)
Figure 92. Israel RNA Drugs Revenue (2018-2034) & (US$ Million)
Figure 93. GCC Countries RNA Drugs Revenue (2018-2034) & (US$ Million)
Figure 94. RNA Drugs Value Chain
Figure 95. RNA Drugs Production Process
Figure 96. Channels of Distribution (Direct Vs Distribution)
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed